Cargando…
IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer
Bone is a common site of metastasis in lung cancer, but the regulatory mechanism remains incompletely understood. Osteoclasts are known to play crucial roles in osteolytic bone metastasis by digesting bone matrix and indirectly enhancing tumor colonization. In this study, we found that IL receptor 2...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566910/ https://www.ncbi.nlm.nih.gov/pubmed/36006737 http://dx.doi.org/10.1172/JCI157917 |
_version_ | 1784809269159264256 |
---|---|
author | He, Yunfei Luo, Wenqian Liu, Yingjie Wang, Yuan Ma, Chengxin Wu, Qiuyao Tian, Pu He, Dasa Jia, Zhenchang Lv, Xianzhe Ma, Yu-Shui Yang, Haitang Xu, Ke Zhang, Xue Xiao, Yansen Zhang, Peiyuan Liang, Yajun Fu, Da Yao, Feng Hu, Guohong |
author_facet | He, Yunfei Luo, Wenqian Liu, Yingjie Wang, Yuan Ma, Chengxin Wu, Qiuyao Tian, Pu He, Dasa Jia, Zhenchang Lv, Xianzhe Ma, Yu-Shui Yang, Haitang Xu, Ke Zhang, Xue Xiao, Yansen Zhang, Peiyuan Liang, Yajun Fu, Da Yao, Feng Hu, Guohong |
author_sort | He, Yunfei |
collection | PubMed |
description | Bone is a common site of metastasis in lung cancer, but the regulatory mechanism remains incompletely understood. Osteoclasts are known to play crucial roles in osteolytic bone metastasis by digesting bone matrix and indirectly enhancing tumor colonization. In this study, we found that IL receptor 20 subunit β (IL-20RB) mediated a direct tumoral response to osteoclasts. Tumoral expression of IL-20RB was associated with bone metastasis of lung cancer, and functionally, IL-20RB promoted metastatic growth of lung cancer cells in bone. Mechanistically, tumor cells induced osteoclasts to secrete the IL-20RB ligand IL-19, and IL-19 stimulated IL-20RB–expressing tumor cells to activate downstream JAK1/STAT3 signaling, leading to enhanced proliferation of tumor cells in bone. Importantly, blocking IL-20RB with a neutralizing antibody significantly suppressed bone metastasis of lung cancer. Overall, our data revealed a direct protumor role of osteoclastic niche in bone metastasis and supported IL-20RB–targeting approaches for metastasis treatment. |
format | Online Article Text |
id | pubmed-9566910 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society for Clinical Investigation |
record_format | MEDLINE/PubMed |
spelling | pubmed-95669102022-10-18 IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer He, Yunfei Luo, Wenqian Liu, Yingjie Wang, Yuan Ma, Chengxin Wu, Qiuyao Tian, Pu He, Dasa Jia, Zhenchang Lv, Xianzhe Ma, Yu-Shui Yang, Haitang Xu, Ke Zhang, Xue Xiao, Yansen Zhang, Peiyuan Liang, Yajun Fu, Da Yao, Feng Hu, Guohong J Clin Invest Research Article Bone is a common site of metastasis in lung cancer, but the regulatory mechanism remains incompletely understood. Osteoclasts are known to play crucial roles in osteolytic bone metastasis by digesting bone matrix and indirectly enhancing tumor colonization. In this study, we found that IL receptor 20 subunit β (IL-20RB) mediated a direct tumoral response to osteoclasts. Tumoral expression of IL-20RB was associated with bone metastasis of lung cancer, and functionally, IL-20RB promoted metastatic growth of lung cancer cells in bone. Mechanistically, tumor cells induced osteoclasts to secrete the IL-20RB ligand IL-19, and IL-19 stimulated IL-20RB–expressing tumor cells to activate downstream JAK1/STAT3 signaling, leading to enhanced proliferation of tumor cells in bone. Importantly, blocking IL-20RB with a neutralizing antibody significantly suppressed bone metastasis of lung cancer. Overall, our data revealed a direct protumor role of osteoclastic niche in bone metastasis and supported IL-20RB–targeting approaches for metastasis treatment. American Society for Clinical Investigation 2022-10-17 /pmc/articles/PMC9566910/ /pubmed/36006737 http://dx.doi.org/10.1172/JCI157917 Text en © 2022 He et al. https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article He, Yunfei Luo, Wenqian Liu, Yingjie Wang, Yuan Ma, Chengxin Wu, Qiuyao Tian, Pu He, Dasa Jia, Zhenchang Lv, Xianzhe Ma, Yu-Shui Yang, Haitang Xu, Ke Zhang, Xue Xiao, Yansen Zhang, Peiyuan Liang, Yajun Fu, Da Yao, Feng Hu, Guohong IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer |
title | IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer |
title_full | IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer |
title_fullStr | IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer |
title_full_unstemmed | IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer |
title_short | IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer |
title_sort | il-20rb mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566910/ https://www.ncbi.nlm.nih.gov/pubmed/36006737 http://dx.doi.org/10.1172/JCI157917 |
work_keys_str_mv | AT heyunfei il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT luowenqian il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT liuyingjie il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT wangyuan il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT machengxin il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT wuqiuyao il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT tianpu il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT hedasa il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT jiazhenchang il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT lvxianzhe il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT mayushui il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT yanghaitang il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT xuke il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT zhangxue il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT xiaoyansen il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT zhangpeiyuan il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT liangyajun il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT fuda il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT yaofeng il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer AT huguohong il20rbmediatestumoralresponsetoosteoclasticnichesandpromotesbonemetastasisoflungcancer |